Product Name :
3-Iodobenzylamine (CAS 696-40-2)

Synonym :

Application :

CAS:
696-40-2

Purity:

Molecular Weight:
233.05

Formula :
C7H8IN

Physical state:
Liquid

solubility :

Shipping Condition :
Store at room temperature

Melting point:

SMILES:
C1=CC(=CC(=C1)I)CN

References:
:Modulation of adenosine receptor affinity and intrinsic efficacy in adenine nucleosides substituted at the 2-position. | Ohno, M., et al. 2004. Bioorg Med Chem. 12: 2995-3007. PMID: 15142558Exploring human adenosine A3 receptor complementarity and activity for adenosine analogues modified in the ribose and purine moiety. | Van Rompaey, P., et al. 2005. Bioorg Med Chem. 13: 973-83. PMID: 15670905(N)-methanocarba 2,N6-disubstituted adenine nucleosides as highly potent and selective A3 adenosine receptor agonists. | Tchilibon, S., et al. 2005. J Med Chem. 48: 1745-58. PMID: 15771421Purine derivatives as ligands for A3 adenosine receptors. | Joshi, BV. and Jacobson, KA. 2005. Curr Top Med Chem. 5: 1275-95. PMID: 16305531Orthogonal activation of the reengineered A3 adenosine receptor (neoceptor) using tailored nucleoside agonists. | Gao, ZG., et al. 2006. J Med Chem. 49: 2689-702. PMID: 16640329Synthesis of 3′-acetamidoadenosine derivatives as potential A3 adenosine receptor agonists. | Chun, MW., et al. 2008. Nucleosides Nucleotides Nucleic Acids. 27: 408-20. PMID: 18404574Regio- and stereoselective synthesis of truncated 3′-aminocarbanucleosides and their binding affinity at the A3 adenosine receptor. | Choi, MJ., et al. 2011. Org Biomol Chem. 9: 6955-62. PMID: 21860878Synthesis and Binding Affinity of Homologated Adenosine Analogues as A3 Adenosine Receptor Ligands. | Lee, HW., et al. 2011. Bull Korean Chem Soc. 32: 1620-1624. PMID: 26120223N6-Substituted 5′-N-Methylcarbamoyl-4′-selenoadenosines as Potent and Selective A3 Adenosine Receptor Agonists with Unusual Sugar Puckering and Nucleobase Orientation. | Yu, J., et al. 2017. J Med Chem. 60: 3422-3437. PMID: 28380296Polypharmacology of N6-(3-Iodobenzyl)adenosine-5′-N-methyluronamide (IB-MECA) and Related A3 Adenosine Receptor Ligands: Peroxisome Proliferator Activated Receptor (PPAR) gamma Partial Agonist and PPAR delta Antagonist Activity Suggests Their Antidiabetic Potential.92-06-8 custom synthesis | Yu, J.929-59-9 Safety Information , et al.PMID:33736721 2017. J Med Chem. 60: 7459-7475. PMID: 28799755Recent Advances in the Synthesis of Peptoid Macrocycles. | Webster, AM. and Cobb, SL. 2018. Chemistry. 24: 7560-7573. PMID: 29356125Epidermal Growth Factor Receptor-Targeted Multifunctional Photosensitizers for Bladder Cancer Imaging and Photodynamic Therapy. | Cheruku, RR., et al. 2019. J Med Chem. 62: 2598-2617. PMID: 30776232Subtle Chemical Changes Cross the Boundary between Agonist and Antagonist: New A3 Adenosine Receptor Homology Models and Structural Network Analysis Can Predict This Boundary. | Lee, Y., et al. 2021. J Med Chem. 64: 12525-12536. PMID: 34435786Sulfur-Phenolate Exchange as a Mild, Fast, and High-Yielding Method toward the Synthesis of Sulfonamides. | van den Boom, AFJ. and Zuilhof, H. 2023. Org Lett. 25: 788-793. PMID: 36720015